Genetic disruption of fra-1 decreases susceptibility to endotoxin-induced acute lung injury and mortality in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 1, 2012, Pages 55-62

  Vaz, Michelle ^a   Reddy, Narsa M ^a,b   Rajasekaran, Subbiah ^a   Reddy, Sekhar P ^a,b   Subbiah, Raja ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Acute lung injury; Cytokines; Fra 1; Host defense; Inflammation

Indexed keywords

CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE RELEASE; GENE DISRUPTION; GENE TARGETING; GENETIC SUSCEPTIBILITY; KNOCKOUT MOUSE; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION;

ACUTE LUNG INJURY; ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; NEUTROPHILS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

MUS;

EID: 84855396743     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0169OC     Document Type: Article

References (37)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-1693. (Pubitemid 41464707)
2. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145. (Pubitemid 33741967)
3. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782-787.
4. Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, Park GY, Sheller JR, Polosukhin VV, Christman JW, Yull FE, et al. Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J Immunol 2007;178:6504-6513. (Pubitemid 46717434)
5. Everhart MB, Han W, Sherrill TP, Arutiunov M, Polosukhin VV, Burke JR, Sadikot RT, Christman JW, Yull FE, Blackwell TS. Duration and intensity of NF-kappaB activity determine the severity of endotoxininduced acute lung injury. J Immunol 2006;176:4995-5005.
6. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-868. (Pubitemid 37383716)
7. Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, Kenner L, Tschachler E, Wagner EF. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther 2008;10:201.
8. Ray N, Kuwahara M, Takada Y, Maruyama K, Kawaguchi T, Tsubone H, Ishikawa H, Matsuo K. C-Fos suppresses systemic inflammatory response to endotoxin. Int Immunol 2006;18:671-677. (Pubitemid 43779057)
9. Takada Y, Ray N, Ikeda E, Kawaguchi T, Kuwahara M, Wagner EF, Matsuo K. Fos proteins suppress dextran sulfate sodium - induced colitis through inhibition of NF-kappaB. J Immunol 2010;184:1014-1021.
10. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, Scheuch H, Angel P, Tschachler E, Wagner EF. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005;437:369-375. (Pubitemid 41613493)
11. Reddy SP, Mossman BT. Role and regulation of activator protein-1 in toxicant-induced responses of the lung. Am J Physiol Lung Cell Mol Physiol 2002;283:L1161-L1178. (Pubitemid 35379247)
12. Cohen DR, Curran T. Fra-1: a serum-inducible, cellular immediate - early gene that encodes a Fos-related antigen. Mol Cell Biol 1988;8:2063-2069.
13. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-246. (Pubitemid 27135992)
14. Vaz M, Bierman AM, Reddy NM, Hassoun PM, Wagner EF, Reddy SP. Genetic disruption of Fra-1/AP-1 transcription factor decreases susceptibility to endotoxin-induced lung inflammation and death in mice. Am J Respir Crit Care Med 2010;181:A1801. (abstract).
15. Schreiber M, Wang ZQ, Jochum W, Fetka I, Elliott C, Wagner EF. Placental vascularisation requires the AP-1 component Fra1. Development 2000;127:4937-4948.
16. Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner L, Amling M, Wagner EF. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 2004;23:2789-2799. (Pubitemid 39013551)
17. Tallquist MD, Soriano P. Epiblast-restricted Cre expression in more mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 2000;26:113-115. (Pubitemid 30158091)
18. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001;20:2390-2400. (Pubitemid 32531297)
19. Lentsch AB, Ward PA. Regulation of experimental lung inflammation. Respir Physiol 2001;128:17-22. (Pubitemid 32771688)
20. Strieter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med 1994;42:640-651.
21. Wagner EF, Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev 2005;208:126-140. (Pubitemid 41746389)
22. Roy S, Charboneau R, Cain K, DeTurris S, Melnyk D, Barke RA. Deficiency of the transcription factor c-Fos increases lipopolysaccharide-induced macrophage interleukin 12 production. Surgery 1999;126: 239-247. (Pubitemid 29382787)
23. Matsumoto M, Einhaus D, Gold ES, Aderem A. Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J Immunol 2004;172:7377-7384. (Pubitemid 38747598)
24. Schonthaler HB, Guinea-Viniegra J, Wagner EF. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis 2011;70: i109-i112.
25. + T-cells into effector Th1 and Th2 cells. Genes Funct 1997;1:51-68.
26. Hartenstein B, Teurich S, Hess J, Schenkel J, Schorpp-Kistner M, Angel P. Th2 cell - specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J 2002;21:6321-6329. (Pubitemid 35448410)
27. Meixner A, Zenz R, Schonthaler HB, Kenner L, Scheuch H, Penninger JM, Wagner EF. Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat Cell Biol 2008;10: 1003-1011.
28. Pflegerl P, Vesely P, Hantusch B, Schlederer M, Zenz R, Janig E, Steiner G, Meixner A, Petzelbauer P, Wolf P, et al. Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci USA 2009;106:20423-20428.
29. Zhang Q, Kleeberger SR, Reddy SP. DEP-induced Fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung. Am J Physiol Lung Cell Mol Physiol 2004;286: L427-L436. (Pubitemid 38129525)
30. Yoshioka K, Deng T, Cavigelli M, Karin M. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc Natl Acad Sci USA 1995;92:4972-4976.
31. Suzuki T, Okuno H, Yoshida T, Endo T, Nishina H, Iba H. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res 1991;19:5537-5542. (Pubitemid 21912952)
32. Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y. Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2D macrophages. Cell Res 2010;20:701-712.
33. Hoffmann E, Thiefes A, Buhrow D, Dittrich-Breiholz O, Schneider H, Resch K, Kracht M. MEK1-dependent delayed expression of Fosrelated antigen-1 counteracts c-Fos and p65 NF-kappaB - mediated interleukin-8 transcription in response to cytokines or growth factors. J Biol Chem 2005;280:9706-9718. (Pubitemid 40409669)
34. Morishita H, Saito F, Kayama H, Atarashi K, Kuwata H, Yamamoto M, Takeda K. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses. Int Immunol 2009;21:457-465.
35. Takada Y, Gresh L, Bozec A, Ikeda E, Kamiya K, Watanabe M, Kobayashi K, Asano K, Toyama Y, Wagner EF, et al. Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1. Oncogene 2011;30:3821-3832.
36. Blackwell TS, Blackwell TR, Christman JW. Impaired activation of nuclear factor - kappaB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol 1997;158:5934-5940. (Pubitemid 127484002)
37. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, Li Z, Evans DB, Abbruzzese JL, Chiao PJ. NF-kappaB and AP-1 connection: mechanism of Nf-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 2004;24:7806-7819. (Pubitemid 39121503)